Adults Living With MDD:
Advanced Discovery Research is looking for adults age 18-74 to participate in clinical research studies. If you qualify, you may be compensated up to $2,400.00 for your participation depending on the study.
If you are diagnosed with major depressive disorder (MDD) regardless of whether you have taken medication or not, you may qualify to participate in one of our clinical research studies.
All study-related visits, medical evaluation, tests, and study drugs will be provided at no cost. In addition, reimbursement for study-related time and travel may be available.
You may qualify if you:
- Are 18 to 74 years of age
- Have been diagnosed with Major Depressive Disorder (MDD)
- Are in a current depressive episode for at least 4 weeks
- Have tried 0-3 antidepressants in the current depressive episode
- Meet additional study criteria
How long will the study last?
Each study is different in the total time to completion. Generally, participants will be in a study for 6-14 weeks. Some studies also have the option to participate in an extension study that could last up to 52 weeks. Participants will have several visits to the clinic for ongoing evaluation to determine how you are responding to the study drug.
What can participants in this study expect?
Generally, there will be three study periods. First, there is a screening period, which can last up to 28 days. During the screening period, doctors will decide if individuals are eligible to participate in the study.
Next is the treatment period, which will last up to 14 weeks. During this time, participants will receive the study drug or a placebo. A placebo is a substance that looks like the study drug but has no study drug in it. Participants will be chosen at random (by chance, like flipping a coin) to receive the study drug or the placebo.
The final portion of the study is the safety follow-up period, which will usually last about 1 week but could be up to 6 weeks. Depending on the study, participants who complete the study may have the opportunity to enter an extension study, where all participants will receive the study drug.
Provide Your Contact Info: